首都儿科研究所及首都医科大学附属首都儿童医学中心关于维护院内制剂合法权益并提醒家长谨慎甄别正品的严正声明

Core Viewpoint - The company has issued a stern statement regarding unauthorized products that mimic its in-house formulations, emphasizing the potential health risks to children and the need for parents to be vigilant in distinguishing legitimate products from counterfeit ones [1][2]. Group 1: Company’s In-House Formulations - The in-house formulations of the company are legally approved and regulated medical institution preparations, including products like "Fu Le Cream" and "Dimethicone Cream," which have received the necessary approvals from the Beijing Drug Administration [1]. - These formulations are developed by the company with standardized quality management and are only available through its outpatient services, internet consultations, and approved partner medical institutions with a physician's prescription [1]. Group 2: Risks of Infringing Products - Infringing products often exhibit characteristics such as similar or nearly identical names, packaging, and misleading claims like "new version" or "special supply," which can mislead parents [2]. - These products lack legitimate approval credentials and may provide false advertising, exaggerating their efficacy or misrepresenting themselves as medical products [2]. - The formulations of these infringing products may be altered, using substandard ingredients, leading to potential health risks for children [2]. Group 3: Legal Actions Against Infringement - The company has engaged a professional legal team to initiate actions against identified infringing manufacturers and sellers, including administrative complaints and civil lawsuits to halt infringement and seek damages [3]. - Reports of non-compliant sales channels will be submitted to regulatory authorities for investigation and enforcement [3]. - A reporting channel for infringement leads has been established, encouraging public vigilance and cooperation [3]. Group 4: Authorized Purchase Channels - Parents are advised to obtain medications only from the company’s medical center or approved partner institutions, ensuring prescriptions are provided by licensed medical professionals [4]. - The company has not authorized any third parties for the promotion or sale of its in-house formulations, reinforcing the importance of using official channels for medication [4].